跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AURO-VALGANCICLOVIR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AURO-VALGANCICLOVIR
Authorized
STANDARD
AURO-VALGANCICLOVIR
auro pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
385ec064d21b0479
Company
auro pharma inc
Type
Standard
Approval Details
Approval Id
385ec064d21b0479
Drug Approval Canada Name
AURO-VALGANCICLOVIR
Product Name
AURO-VALGANCICLOVIR
Status
Marketed
Status Date
2023-09-13
Original Market Date
2023-09-13
Din
02535483
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:18.32
Atc Original
J05AB14 VALGANCICLOVIR
Atc Name
j 05 ab 14
Aig Number
0147203002
Company Name
auro pharma inc
Company Address
3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8
Active Ingredients
VALGANCICLOVIR (VALGANCICLOVIR HYDROCHLORIDE)
50 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
385ec064d21b0479
Type
Standard
Back to Health Canada Approvals